GET THE APP

Human papillomavirus infection in genital women in four regions o | 58640
Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

Human papillomavirus infection in genital women in four regions of Senegal


4th International Conference on Applied Microbiology, Antibiotics, Antimicrobials and Beneficial Microbes

May 20-21, 2019 Tokyo, Japan

El Hadji Seydou Mbaye, Tarik Gheit, Ahmadou Dem, Sandrine McKay Chopin, Ndeye Coumba Toure-Kane, Souleymane Mboup, Massimo Tommasino, Bakary S Sylla and Cheikh Saad Bouh Boye

International Agency for Research on Cancer, France
Hospital Center University Aristide Le Dantec, Senegal

Scientific Tracks Abstracts: J Clin Cell Immunol

Abstract :

Introduction: Cervical cancer is the most frequent cancer among women in Senegal. However, there are few data concerning the Human Papillomavirus Infection (HPV) types inducing neoplasia and cervical cancers and their prevalence in the general population of Senegal.

Aims: The aim of this study is to determine the prevalence of HPV infection in Senegalese women aged from 18 years and older.

Methods: A study was performed on 498 cervix samples collected from healthy women aged 18 and older in Dakar. 438 other samples were collected from three other regions, Thiès, Saint Louis and Louga. The samples were screened for 21 HPV genotypes using an HPV type-specific E7 PCR bead-based multiplex genotyping assay (TS-MPG) which is a laboratorydeveloped method for the detection of HPV.

Results: The prevalence for pHR/HR-HPV in the region of Dakar was 20.68%. HPV 52 (3.21%) was the most prevalent HPV type, followed by HPV 16 (3.01%) and HPV 31 (3.01%). In the regions of Thiès, Louga and Saint Louis, the prevalence for pHR/ HR-HPV was 29.19%, 23.15% and 20%, respectively.

Conclusion: The study revealed the specificity of the HR-HPV prevalence in Dakar and other regions of Senegal. The patterns differ from the one observed in the other regions of the world and raise the issue of the development of vaccination program in the country. Such a program should consider the real HPV prevalence for an effective protection of HPV-associated diseases.

Biography :

El Hadji Seydou Mbaye has pursued his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC)/ WHO, Lyon, France and Master of Life and Health, Specialty Biology of Microorganisms, Virology in Louis Pasteur University of Strasbourg, France. He is an Editorial Board Member of the International Journal of Immunology, Journal of Retro Virology and Anti Retro Virology.

E-mail: seydou27@hotmail.com

 

Top